Efficacy and safety of natalizumab extended interval dosing
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference18 articles.
1. Extended interval dosing of natalizumab: a two-center, 7-year experience;Bomprezzi;Ther. Adv. Neurol. Disord.,2014
2. Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results;Butzkueven;J. Neurol. Neurosurg. Psychiatry,2014
3. JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab;Frohman;JAMA Neurol.,2014
4. The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing;Kempen;Multiple Sclerosis J.,2018
5. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function;Khatri;Neurology,2009
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience;Neurotherapeutics;2024-04
2. Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients: a systematic review and meta-analysis;Acta Neurologica Belgica;2024-03-08
3. Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines;Multiple Sclerosis and Related Disorders;2024-03
4. Multiple sclerosis and pregnancy management;Clinical Aspects of Multiple Sclerosis Essentials and Current Updates;2024
5. Multiple sclerosis;The Rose and Mackay Textbook of Autoimmune Diseases;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3